Gilead, Cipla Ink Deal To End HIV Drug Buyers' Antitrust Suit
By Gina Kim · March 1, 2024, 6:47 PM EST
Gilead Sciences Inc. and generics maker Cipla told a California federal judge Friday they've reached a settlement ending a proposed class action filed by a public employees' health insurance fund over...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login